Why the study?
The 2023 focused clinical update was motivated by the need to provide up-to-date recommendations on heart failure treatment and management based on recent major clinical trials and meta-analyses since 2021.
This article summarizes the 2023 ESC focused clinical update on heart failure, translating recent major trial evidence into updated clinical practice recommendations.
Summarizes ESC 2023 HF updates for practice; extends prior guidelines while leaving implementation and subgroup questions open.
This article provides an overview of the European Society of Cardiology 2023 focused clinical update on heart failure and considerations for practice. The latest focused clinical update provides an overview of up-to-date recommendations based on all major clinical trials and meta-analyses exploring heart failure that were published since 2021. The update outlined recommendations on treatment and management of chronic heart failure, acute heart failure, and comorbidities (including chronic kidney disease, type 2 diabetes, iron deficiency) and the prevention of heart failure.
No takes yet. Share an insight, caveat, or question.
Lehane et al. (2024) conducted a review in Heart failure. European Society of Cardiology 2023 focused clinical update was evaluated. The 2023 European Society of Cardiology focused clinical update provides new recommendations for the treatment and management of chronic and acute heart failure, comorbidities, and prevention.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: